semaglutide patent expiry 2031 opens door to GLP-1 generics in Canada semaglutide patent expiration us 2031

are maintained at such artificially high levels compared to every other large-market country in the world, restricting demand for brand-name meds but increasing demand for compounded meds. We call on policymakers and regulators to take into account this increase in demand and maintain compounding exemptions until the price of the brand-name medications in New York and Los Angeles match their price in London and Sydney

NEJM SELECT trial (fulltext)

A highly simulated scar model developed by grafting human thin split-thickness skin on back of nude mouse: the remodeling process, histological characteristics of scars

Am J Med Genet A